ALIS plus macrolide regimen improves culture conversion in noncavitary MAC lung disease
An Inhaled Antibiotic Shifts the Odds in a Stealthy Lung Infection
In a 99-patient RCT of adults with noncavitary MAC lung disease, adding 6 months of amikacin liposome inhalation suspension (ALIS) to a macr…
Adding a nebulized antibiotic to standard pills helped more newly diagnosed MAC lung patients clear the bug sooner, with no new safety surpr…
In vitro amikacin resistance linked to kanamycin cross-resistance but not streptomycin in M. avium-intracellulare complex
Lost to Amikacin? Streptomycin Might Still Work
This single-center retrospective study evaluated cross-resistance among aminoglycosides in 20 patients with amikacin-resistant M.
When amikacin fails to treat stubborn lung infections, streptomycin often remains effective, offering hope for patients facing drug-resistan…
Research across Nontuberculous Mycobacterial Infection
Related studies from across the Nontuberculous Mycobacterial Infection family.
Quadruple antimycobacterial regimen achieves clinical stability in cystic fibrosis patient with M. abscessus
Case report shows quadruple regimen for cystic fibrosis infection
A case report and literature review describes a 21-year-old man with cystic fibrosis and Mycobacterium abscessus infection who achieved clin…
A young man with cystic fibrosis and a hard-to-treat infection achieved stability using a four-drug antimycobacterial regimen.
Systematic review of Mycobacterium riyadhense infection in 69 cases shows common presentations and drug susceptibility patterns
A rare infection hits lungs and bones: what doctors need to know about treating Mycobacterium riyadhense
A systematic review and meta-analysis of 69 immunocompetent and immunocompromised patients with Mycobacterium riyadhense infection found pne…
A rare lung and bone infection called Mycobacterium riyadhense often resists standard drugs, leaving doctors without agreed-upon treatment p…